NeuroSense Therapeutics | Investor Presentation Deck | 34 slides · page 17 of 34
Data shows p-values of 0.005 and <0.001 for treated groups, indicating significant biomarker reduction.
Pitch deck · traction · show_traction · balanced density
Slide locked Sign in to view
Slide schematic 5/5
chart 2/2 other 1/1 paragraph 1/1 title 1/1
Components 5
line line unclassified paragraph headline
Tools 1
Metrics 0
∅
No metrics
No metric insight is anchored to this slide.
Frameworks 0
∅
No frameworks
No framework match is anchored to this slide.